Muskelinvasives Blasenkarzinom

Jakob Büchler; Jürgen E. Gschwend; Margitta Retz; Sebastian C. Schmid

doi:10.1007/s00120-021-01536-2

Muskelinvasives Blasenkarzinom

Jakob Büchler, Jürgen E. Gschwend, Margitta Retz, Sebastian C. Schmid

Technische Universität München

Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

1 Zitat (Scopus)

Abstract

Bladder cancer, which is a complex disease, can be treated with a variety of stage-oriented treatment options. In this article, the treatment recommendations of the German S3 guideline “Early detection, diagnosis, treatment and aftercare of bladder cancer” are applied in a fictitious case study. In a patient with invasive transitional cell carcinoma, the treatment options—ranging from bladder preservation to radical cystectomy with neoadjuvant chemotherapy—are discussed on the basis of the current literature.

Titel in Übersetzung	Muscle-invasive bladder cancer
Originalsprache	Deutsch
Seiten (von - bis)	769-775
Seitenumfang	7
Fachzeitschrift	Urologe - Ausgabe A
Jahrgang	60
Ausgabenummer	6
DOIs	https://doi.org/10.1007/s00120-021-01536-2
Publikationsstatus	Veröffentlicht - Juni 2021

Schlagwörter

BCG
Chemotherapy, neoadjuvant
Cystectomy
Transurethral resection
Urinary bladder neoplasms
Urinary division

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.1007/s00120-021-01536-2

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{9854943615ad471cbea8feb43ed1265a,

title = "Muskelinvasives Blasenkarzinom",

abstract = "Bladder cancer, which is a complex disease, can be treated with a variety of stage-oriented treatment options. In this article, the treatment recommendations of the German S3 guideline “Early detection, diagnosis, treatment and aftercare of bladder cancer” are applied in a fictitious case study. In a patient with invasive transitional cell carcinoma, the treatment options—ranging from bladder preservation to radical cystectomy with neoadjuvant chemotherapy—are discussed on the basis of the current literature.",

keywords = "BCG, Chemotherapy, neoadjuvant, Cystectomy, Transurethral resection, Urinary bladder neoplasms, Urinary division",

author = "Jakob B{\"u}chler and Gschwend, {J{\"u}rgen E.} and Margitta Retz and Schmid, {Sebastian C.}",

note = "Publisher Copyright: {\textcopyright} 2021, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.",

year = "2021",

month = jun,

doi = "10.1007/s00120-021-01536-2",

language = "Deutsch",

volume = "60",

pages = "769--775",

journal = "Urologe - Ausgabe A",

issn = "0340-2592",

publisher = "Springer Medizin",

number = "6",

}

TY - JOUR

T1 - Muskelinvasives Blasenkarzinom

AU - Büchler, Jakob

AU - Gschwend, Jürgen E.

AU - Retz, Margitta

AU - Schmid, Sebastian C.

PY - 2021/6

Y1 - 2021/6

N2 - Bladder cancer, which is a complex disease, can be treated with a variety of stage-oriented treatment options. In this article, the treatment recommendations of the German S3 guideline “Early detection, diagnosis, treatment and aftercare of bladder cancer” are applied in a fictitious case study. In a patient with invasive transitional cell carcinoma, the treatment options—ranging from bladder preservation to radical cystectomy with neoadjuvant chemotherapy—are discussed on the basis of the current literature.

AB - Bladder cancer, which is a complex disease, can be treated with a variety of stage-oriented treatment options. In this article, the treatment recommendations of the German S3 guideline “Early detection, diagnosis, treatment and aftercare of bladder cancer” are applied in a fictitious case study. In a patient with invasive transitional cell carcinoma, the treatment options—ranging from bladder preservation to radical cystectomy with neoadjuvant chemotherapy—are discussed on the basis of the current literature.

KW - BCG

KW - Chemotherapy, neoadjuvant

KW - Cystectomy

KW - Transurethral resection

KW - Urinary bladder neoplasms

KW - Urinary division

UR - http://www.scopus.com/inward/record.url?scp=85106244181&partnerID=8YFLogxK

U2 - 10.1007/s00120-021-01536-2

DO - 10.1007/s00120-021-01536-2

M3 - Übersichtsartikel

C2 - 34014342

AN - SCOPUS:85106244181

SN - 0340-2592

VL - 60

SP - 769

EP - 775

JO - Urologe - Ausgabe A

JF - Urologe - Ausgabe A

IS - 6

ER -

Muskelinvasives Blasenkarzinom

Abstract

Schlagwörter

UN SDGs

Zugriff auf Dokument

Andere Dateien und Links

Fingerprint

Dieses zitieren